Cardiovascular Diabetology
| Discipline | Cardiology, diabetology |
|---|---|
| Language | English |
| Edited by | Enrique Fisman co-founder and editor-in-chief, Francisco Westermeier deputy editor |
| Publication details | |
| History | 2002-present |
| Publisher | |
| Yes | |
| License | Creative Commons Attribution |
| 10.6 (2024) | |
| Standard abbreviations | |
| ISO 4 | Cardiovasc. Diabetol. |
| Indexing | |
| ISSN | 1475-2840 |
| OCLC no. | 848273564 |
| Links | |
Cardiovascular Diabetology is a peer-reviewed open access medical journal covering the intersection of cardiology and diabetology, meaning the connection between diabetes, metabolic syndrome and cardiovascular diseases. It is published by BioMed Central (a part of Springer Nature since 2008) and was established in 2002, with professors Enrique Fisman (Tel Aviv University) and Alexander Tenenbaum (Sheba Medical Center) as founding editors-in-chief. Alexander Tenenbaum died in 2022. In 2024, Dr. Francisco Westermeier (FH Joanneum) was appointed deputy editor. In addition, the journal currently has 80 associate editors.
Scope
Cardiovascular Diabetology considers for publications manuscripts on all aspects of the diabetes/cardiovascular interrelationship, including clinical, genetic, experimental, pharmacological, epidemiological, molecular biology and laboratory research. Seven article types maybe considered for publication: original investigations, reviews, case reports, commentaries, hypotheses, methodology articles and study protocols; most of published papers are original investigations. Articles are published online upon acceptance, rather than in issues. A printed version is periodically distributed in India by Panacea Biotec Ltd.
Abstracting and indexing
The journal is abstracted and indexed in Baidu, Chemical Abstracts Service (CAS), Citebase, Current Contents, Dimensions (database), EBSCO Information Services, Directory of Open Access Journals (DOAJ), EMBASE, Japanese Science and Technology Agency (JST), MEDLINE/PubMed, Naver, Science Citation Index, SCImago Journal Rank, Scopus, Socolar, Wanfang and several additional scientific repositories.[1] According to the Journal Citation Reports, the journal has a 2024 impact factor of 10.6, ranking it in the 94.1 JIF percentile (11 out of 191 journals) in the category of "Endocrinology & Metabolism", and in the 94.7 JIF percentile (14 out of 230 journals) in the category "Cardiac & Cardiovascular Systems" journals.[2]
References
- ^ "About". BioMed Central. Retrieved 26 November 2025.
- ^ "Cardiovascular Diabetology". 2025 Journal Citation Reports. Web of Science (Science ed.). Clarivate Analytics. 2024.
External links